肺癌
Scientists map proteins that let carcinomas change identity
由 AI 报道 AI 生成的图像 事实核查
Researchers at Cold Spring Harbor Laboratory have identified key proteins and protein complexes that help certain carcinomas shift their cellular identity and potentially evade treatment. Two new studies, focusing on pancreatic cancer and tuft cell lung cancer, highlight molecular structures that could become targets for more precise and selective therapies.
一项针对晚期肺癌患者的研究显示，早晨时段接受免疫化疗可显著延长生存时间。香港医学专家表示，这一发现为优化治疗时机提供了可能性，但需进一步研究。该研究由湖南癌症医院主导，并获香港中文大学医学系支持。
由 AI 报道
Researchers in Japan have uncovered how cancer cells use tiny vesicles to spread the immune-suppressing protein PD-L1, explaining why immunotherapy often fails. A protein called UBL3 directs this process, but common statins can disrupt it, potentially boosting treatment effectiveness. The findings, from patient samples and lab tests, suggest a simple way to improve outcomes for lung cancer patients.
Researchers have identified a novel protein biomarker that detects lung cancer at an early stage with high accuracy. The discovery, detailed in a recent study, could enhance screening methods and improve patient outcomes. Clinical trials showed promising results in identifying the disease before symptoms appear.